The Etiology of Acute Febrile Illness Requiring Hospitalization
NCT ID: NCT02763462
Last Updated: 2023-05-03
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1492 participants
OBSERVATIONAL
2013-07-31
2017-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Observational Research on Infectious Disease Outbreaks and Difficult Cases of Unidentified Etiology in Indonesia
NCT04339179
Implementing a Combination of Clinical Parameters, Biomarkers and SoCs for the Etiology Diagnoses of Pneumonia in Pediatric Patients
NCT03366454
Promotion and Application of a New Three-level Etiological Diagnosis Strategy for Fever Clinics in Respiratory Infectious Diseases
NCT05965128
The Fever Clinic Acute Respiratory Cohort
NCT07278700
Diagnosis and Management of Inflammatory and Infectious Diseases
NCT00557726
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Primary Objective:
To identify the etiology of acute febrile illness cases and evaluate clinical manifestations and outcomes.
Secondary Objectives:
1. To provide clinical data that are essential for improving and/or developing clinical management and health policies.
2. To enhance research capacity and networking for infectious diseases in Indonesia by improving clinical research site capability in conducting research relevant to public health.
3. To establish a repository of biological specimens for future study, such as determining the etiology of undiagnosed fever and/or its pathogenicity and its public health importance.
This study will be conducted at all the INA-RESPOND hospitals (8 hospitals):
* Dr. Cipto Mangunkusumo Hospital , Jakarta
* Penyakit Infeksi Prof. Dr. Sulianti Saroso Hospital, Jakarta
* Dr. Hasan Sadikin Hospital, Bandung
* Dr. Kariadi Hospital, Semarang
* Dr. Sardjito Hospital, Yogyakarta
* Dr. Soetomo Hospital, Surabaya
* Sanglah Hospital, Bali
* Dr. Wahidin Soedirohusodo Hospital, Makassar
The study will enroll eligible fever patients for a period of up to 1 year. Follow-up may be up until one year after last subject is enrolled. Stored samples will be investigated during the study and/or after study completion.
After enrollment, patients will be seen at 14-28 days and at 3 months post enrollment. Patients will be seen every 3 months (6, 9, and 12 months within a window period of +/- 14 days) until cured and no related symptoms persists or the one year time point is reached. The samples will be collected for storage at enrollment, the 14-28 day visit, at 3 months and every 3 months thereafter if not cured.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Acute febrile illness requiring hospitalization (fever defined as temperature recorded ≥38.0°C during the first 24 hour period of hospitalization).
* Hospitalized within the past 24 hours.
* Willing to allow storage of blood and other specimens for use in future studies of infectious diseases.
Exclusion Criteria
* Inpatient transfer from another hospital.
* A known medical disorder or other circumstance, which in the opinion of the PI might make the participation of the individual unsafe or difficult.
Examples include, but not limited to: mental illness which could affect compliance with protocol, an anemic patient preventing blood draw.
1 Year
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Health Research and Development, Ministry of Health Republic of Indonesia
OTHER
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
Ina-Respond
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Prof. dr. M. Hussein Gasem, PhD, SpPD-KPTI
Role: PRINCIPAL_INVESTIGATOR
University of Diponegoro/ Dr. Kariadi hospital
Prof. Emiliana Tjitra, MSC, Ph.D
Role: PRINCIPAL_INVESTIGATOR
NIHRD, Indonesia
Dr. Bachti Alisjahbana, PhD, SpPD-KPTI
Role: PRINCIPAL_INVESTIGATOR
Univerversity of Padjajaran / Dr. Hasan Sadikin Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Udayana/Sanglah Hospital
Denpasar, Bali, Indonesia
University of Diponegoro/ Dr. Kariadi Hospital
Semarang, Central Java, Indonesia
University of Indonesia/ Dr. Cipto Mangunkusumo Hospital
Jakarta, DKI Jakarta, Indonesia
Penyakit Infeksi Sulianti Saroso Hospital
Jakarta, DKI Jakarta, Indonesia
University of Airlangga/ Dr. Soetomo Hospital
Surabaya, East Java, Indonesia
University of Padjajaran/ Dr. Hasan Sadikin Hospital
Bandung, West Java, Indonesia
University of Hassanudin/ Dr. Wahidin Sudirohusodo Hospital
Makassar, , Indonesia
University of Gadjah Mada/ Dr. Sardjito Hospital
Yogyakarta, , Indonesia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
U1111-1263-2248
Identifier Type: OTHER
Identifier Source: secondary_id
HHSN261200800001E
Identifier Type: OTHER
Identifier Source: secondary_id
HHSN261201500003I
Identifier Type: OTHER
Identifier Source: secondary_id
INA101
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.